Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Yisaipu and DMARDs in Ankylosing Spondylitis
NCT03411798Phase 4Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Dec 2017
- Primary completion
- Jul 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept in ankylosing spondylitis (AS), sponsored by Nanfang Hospital, Southern Medical University. Started Dec 2017; status: completed.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT03411798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03411798.